Sunder Venkatesulu, MD | |
796 Newtown Yardley Rd Ste 200, Newtown, PA 18940-1748 | |
(215) 860-3344 | |
Not Available |
Full Name | Sunder Venkatesulu |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 35 Years |
Location | 796 Newtown Yardley Rd Ste 200, Newtown, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437148210 | NPI | - | NPPES |
7945701 | Medicaid | NJ |
Facility Name | Location | Facility Type |
---|---|---|
Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
St Mary Medical Center | Langhorne, PA | Hospital |
Capital Health Regional Medical Center | Trenton, NJ | Hospital |
Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capital Health Medical Group | 7618264532 | 364 |
Capital Health Medical Group | 7618264532 | 364 |
News Archive
PROLOR Biotech, Inc., today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering the company's CTP platform, which has the potential to extend the duration of activity of virtually all therapeutic proteins.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.
A political 527 group, which claims responsibility for derailing Mitt Romney's presidential hopes in 2008 in the early-contest states of Iowa and South Carolina, is now targeting Sarah Palin.
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 1 days ago
Entity Name | Mercer Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124369822 PECOS PAC ID: 2264670330 Enrollment ID: O20130531000026 |
News Archive
PROLOR Biotech, Inc., today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering the company's CTP platform, which has the potential to extend the duration of activity of virtually all therapeutic proteins.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.
A political 527 group, which claims responsibility for derailing Mitt Romney's presidential hopes in 2008 in the early-contest states of Iowa and South Carolina, is now targeting Sarah Palin.
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 1 days ago
Entity Name | Capital Health Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20160921000449 |
News Archive
PROLOR Biotech, Inc., today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering the company's CTP platform, which has the potential to extend the duration of activity of virtually all therapeutic proteins.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.
A political 527 group, which claims responsibility for derailing Mitt Romney's presidential hopes in 2008 in the early-contest states of Iowa and South Carolina, is now targeting Sarah Palin.
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Sunder Venkatesulu, MD 104 Pheasant Run, Suite 129, Newtown, PA 18940-3439 Ph: (215) 860-3344 | Sunder Venkatesulu, MD 796 Newtown Yardley Rd Ste 200, Newtown, PA 18940-1748 Ph: (215) 860-3344 |
News Archive
PROLOR Biotech, Inc., today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering the company's CTP platform, which has the potential to extend the duration of activity of virtually all therapeutic proteins.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.
A political 527 group, which claims responsibility for derailing Mitt Romney's presidential hopes in 2008 in the early-contest states of Iowa and South Carolina, is now targeting Sarah Palin.
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 1 days ago
Scott Walter Burke, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Pheasant Run, Newtown, PA 18940 Phone: 215-860-3344 Fax: 215-860-3348 | |
Craig Joseph Mcmackin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Pheasant Run, Suite 128, Newtown, PA 18940 Phone: 215-860-3344 Fax: 215-860-8950 | |
Arianna Hope Sanborn, APN Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 473 Trumbull Ct, Newtown, PA 18940 Phone: 207-812-5431 | |
Paula S Seth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Pheasant Run, Suite 128, Newtown, PA 18940 Phone: 215-860-3344 Fax: 215-860-8950 | |
Richard Dennis Gordon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Penns Trl Fl 2, Newtown, PA 18940 Phone: 609-303-4360 Fax: 609-303-4361 | |
Dr. Albert Ruben Castano, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 Newtown Yardley Rd, Newtown, PA 18940 Phone: 215-860-2990 | |
George Patrick Heyrich, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Pheasant Run, Suite 128, Newtown, PA 18940 Phone: 215-860-3344 Fax: 215-860-8950 |